Overall market sentiment has been neutral on Evogene Ltd (EVGN) stock lately. EVGN receives a Neutral rating from InvestorsObserver Stock Sentiment Indicator.
Evogene Ltd has a Neutral sentiment reading. Find out what this means for you and get the rest of the rankings on EVGN!
When making investment decisions, sentiment gives a good overview of what stocks investors currently favor. Sentiment incorporates short-term technical analysis into its score and does not encompass any fundamental analysis such as profitability of the company. This means that earnings updates and other news can greatly impact overall sentiment.
Sentiment is how investors, or the market, feels about a stock. There are lots of ways to measure sentiment. At the core, sentiment is pretty easy to understand. If a stock is going up, investors must be bullish, while if it is going down, sentiment is bearish.
InvestorsObserver’s Sentiment Indicator looks at price trends over the past week and also considers changes in volume. Increasing volume can mean a trend is getting stronger, while decreasing volume can mean a trend is nearing a conclusion.
For stocks that have options, our system also considers the balance between calls, which are often bets that the price will go up, and puts, which are frequently bets that the price will fall.
What's Happening With EVGN Stock Today?
Evogene Ltd (EVGN) stock is trading at $2.06 as of 3:46 PM on Monday, Nov 29, an increase of $0.03, or 1.43% from the previous closing price of $2.03. The stock has traded between $2.02 and $2.14 so far today. Volume today is above average. So far 438,536 shares have traded compared to average volume of 328,158 shares.
More About Evogene Ltd
Evogene Ltd is a computational biology company targeting to revolutionize product development for life-science based industries, including human health, agriculture, and industrial applications. The company established its technology, the Computational Predictive Biology (CPB) platform. The CPB platform is designed to computationally discover and develop life-science products based on microbes, small molecules and genetic elements as the core components for such products. It holds a number of subsidiaries utilizing the CPB platform, for the development of human microbiome-based therapeutics, medical cannabis, ag-biologicals, ag-chemicals, seed traits and ag-solutions for castor oil production. It generates maximum revenue from the Agriculture segment.
Click Here to get the full Stock Report for Evogene Ltd stock.
Share this article:
Stay In The Know
Subscribe to our daily morning update newsletter and never miss out on the need-to-know market news, movements, and more.
Thank you for signing up! You're all set to receive the Morning Update newsletter
